434 related articles for article (PubMed ID: 19751169)
1. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
Beech J; Boston RC; McFarlane D; Lindborg S
J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169
[TBL] [Abstract][Full Text] [Related]
2. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
Copas VE; Durham AE
Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
[TBL] [Abstract][Full Text] [Related]
3. α-Melanocyte--stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction.
Beech J; McFarlane D; Lindborg S; Sojka JE; Boston RC
J Am Vet Med Assoc; 2011 May; 238(10):1305-15. PubMed ID: 21568777
[TBL] [Abstract][Full Text] [Related]
4. The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses.
Lee ZY; Zylstra R; Haritou SJ
Vet J; 2010 Jul; 185(1):58-61. PubMed ID: 20537574
[TBL] [Abstract][Full Text] [Related]
5. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
Beech J; Boston R; Lindborg S; Russell GE
J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
[TBL] [Abstract][Full Text] [Related]
6. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
McFarlane D; Beech J; Cribb A
Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of basal plasma α-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses.
Mc Gowan TW; Pinchbeck GP; Mc Gowan CM
Equine Vet J; 2013 Jan; 45(1):66-73. PubMed ID: 22563728
[TBL] [Abstract][Full Text] [Related]
8. Circadian and circannual rhythms of cortisol, ACTH, and α-melanocyte-stimulating hormone in healthy horses.
Cordero M; Brorsen BW; McFarlane D
Domest Anim Endocrinol; 2012 Nov; 43(4):317-24. PubMed ID: 22717182
[TBL] [Abstract][Full Text] [Related]
9. Seasonal variation in results of diagnostic tests for pituitary pars intermedia dysfunction in older, clinically normal geldings.
Schreiber CM; Stewart AJ; Kwessi E; Behrend EN; Wright JC; Kemppainen RJ; Busch KA
J Am Vet Med Assoc; 2012 Jul; 241(2):241-8. PubMed ID: 22765372
[TBL] [Abstract][Full Text] [Related]
10. The effect of geographic location, breed, and pituitary dysfunction on seasonal adrenocorticotropin and α-melanocyte-stimulating hormone plasma concentrations in horses.
McFarlane D; Paradis MR; Zimmel D; Sykes B; Brorsen BW; Sanchez A; Vainio K
J Vet Intern Med; 2011; 25(4):872-81. PubMed ID: 21745243
[TBL] [Abstract][Full Text] [Related]
11. Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction.
Rendle DI; Litchfield E; Heller J; Hughes KJ
Equine Vet J; 2014 Jan; 46(1):113-7. PubMed ID: 23742059
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction.
Beech J; Boston R; Lindborg S
J Vet Intern Med; 2011; 25(6):1431-8. PubMed ID: 22092639
[TBL] [Abstract][Full Text] [Related]
13. Seasonal changes in plasma adrenocorticotropic hormone and α-melanocyte-stimulating hormone in response to thyrotropin-releasing hormone in normal, aged horses.
Funk RA; Stewart AJ; Wooldridge AA; Kwessi E; Kemppainen RJ; Behrend EN; Zhong Q; Johnson AK
J Vet Intern Med; 2011; 25(3):579-85. PubMed ID: 21457320
[TBL] [Abstract][Full Text] [Related]
14. Measurement of cortisol concentration in the tears of horses and ponies with pituitary pars intermedia dysfunction.
Hart KA; Kitchings KM; Kimura S; Norton NA; Myrna KE
Am J Vet Res; 2016 Nov; 77(11):1236-1244. PubMed ID: 27805438
[TBL] [Abstract][Full Text] [Related]
15. The effects of sample handling and N-phenylmaleimide on concentration of adrenocorticotrophic hormone in equine plasma.
Rendle DI; Litchfield E; Gough S; Cowling A; Hughes KJ
Equine Vet J; 2015 Sep; 47(5):587-91. PubMed ID: 24980684
[TBL] [Abstract][Full Text] [Related]
16. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE
Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571
[TBL] [Abstract][Full Text] [Related]
17. Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses.
McFarlane D; Cribb AE
Am J Vet Res; 2005 Dec; 66(12):2065-72. PubMed ID: 16379648
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil function in healthy aged horses and horses with pituitary dysfunction.
McFarlane D; Hill K; Anton J
Vet Immunol Immunopathol; 2015 Jun; 165(3-4):99-106. PubMed ID: 25962580
[TBL] [Abstract][Full Text] [Related]
19. Association of season and pasture grazing with blood hormone and metabolite concentrations in horses with presumed pituitary pars intermedia dysfunction.
Frank N; Elliott SB; Chameroy KA; Tóth F; Chumbler NS; McClamroch R
J Vet Intern Med; 2010; 24(5):1167-75. PubMed ID: 20666984
[TBL] [Abstract][Full Text] [Related]
20. Profiles of pro-opiomelanocortin and encoded peptides, and their processing enzymes in equine pituitary pars intermedia dysfunction.
Carmalt JL; Mortazavi S; McOnie RC; Allen AL; Unniappan S
PLoS One; 2018; 13(1):e0190796. PubMed ID: 29309431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
